๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The value of randomised trials for prostate cancer management

โœ Scribed by Loblaw, Andrew

Book ID
122222985
Publisher
The Lancet
Year
2014
Tongue
English
Weight
153 KB
Volume
15
Category
Article
ISSN
1470-2045

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

European trials and the management of pr
European trials and the management of prostate cancer
โœ D. W. W. Newling ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 672 KB

Efforts continue to improve the outlook for patients with all stages of prostate cancer. The addition of adjuvant or neo-adjuvant hormone therapy to radical prostatectomy may improve the curability of advanced localized disease. Various novel forms of maximal androgen blockade continue to be explore

Dutasteride in localised prostate cancer
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial
โœ Neil E Fleshner; M Scott Lucia; Blair Egerdie; Lorne Aaron; Gregg Eure; Indrani ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› The Lancet ๐ŸŒ English โš– 217 KB

Background We aimed to investigate the safety and effi cacy of dutasteride, a 5ฮฑ-reductase inhibitor, on prostate cancer progression in men with low-risk disease who chose to be followed up with active surveillance. Methods In our 3 year, randomised, double-blind, placebo-controlled study, undertak